abstract: MicroRNA let-7a: A potential marker for selection of paclitaxel in ovarian cancer management.

CONCLUSIONS:

The study suggests that the beneficial impact of the addition of paclitaxel on EOC survival was significantly linked to let-7a levels, and that miRNAs such as let-7a may be a useful marker for selection of chemotherapeutic agents in EOC management.